Persistent Reflux Symptoms With a Normal Endoscopy: What Next?

Yes. A normal endoscopy can be reassuring about the lining examined without explaining ongoing heartburn or regurgitation. It does not by itself exclude gastroesophageal reflux disease, called GERD or GORD, or prove that acid reflux is causing every symptom. The useful next step is to understand the report alongside the symptom pattern, treatment and any earlier evidence of reflux disease.

This guide is for adults preparing for follow-up after an upper endoscopy, also called gastroscopy. The central question is what has been established and what remains uncertain. Persistent symptoms do not automatically mean that you need another scope, stronger medicine or a particular diagnosis.

Contact a clinician promptly about new or worsening difficulty swallowing, painful swallowing, persistent vomiting, unexplained weight loss or a newly identified unexplained iron-deficiency anemia. These are alarm features in specialist guidance. Explain what has changed since the procedure; an earlier normal result should not delay reassessment.

Get medical help for vomiting blood or material resembling coffee grounds. Emergency care is needed if this occurs with feeling unwell, faintness, confusion, abnormal breathing, clammy skin, abdominal pain or black stools. Even if the vomiting has stopped and there are no other symptoms, seek urgent advice.

New black, tarry stools need medical advice right away, even without vomiting blood. If bleeding is accompanied by fainting, confusion, or cold, sweaty skin with a fast heartbeat, seek emergency care.

Seek emergency help for sudden chest pain or discomfort that does not go away, pain spreading to the arm, neck, jaw or back, or chest pain with sweating, sickness, lightheadedness or breathlessness. A heart attack can feel like burning or indigestion. Do not assume it is reflux or drive yourself for emergency care.

Upper endoscopy lets the doctor inspect the lining of the esophagus, stomach and duodenum. NIDDK explains that it may be used to assess reflux complications or other explanations for symptoms. If tissue samples were collected, a pathologist examines them separately. A reassuring visual report and completed biopsy results are different pieces of information.

Ask which areas were examined, what findings were recorded and whether any results remain pending. If biopsies were taken, ask what they were intended to assess. If none were taken, ask what the clinician concluded from the overall assessment; their absence is not a reason to assume that every possible condition was excluded or that the procedure must be repeated.

The American College of Gastroenterology notes that normal lining is common in people investigated for typical reflux symptoms. Acid-suppressing treatment can also heal erosive changes, affecting what an examination shows. The clinician therefore needs to know what you were taking around the endoscopy and how that fits the question being investigated.

Record the actual treatment and any instructions you received. This is context for interpreting the report, not a reason to change treatment for a future test yourself. A normal examination during treatment does not automatically mean there was never reflux-related injury, and ongoing symptoms do not prove that such injury is present now.

AGA guidance distinguishes people with objectively established, or ‘proven,’ GERD from those whose diagnosis remains unproven. Evidence may come from relevant endoscopic findings or previous reflux monitoring. Having been prescribed reflux medicine is not, on its own, the same as having that objective evidence.

Ask: ‘What evidence supports the diagnosis in my record?’ If GERD has not been established, an assessment may aim to determine whether abnormal reflux is present. If it has been established, the question may instead be why symptoms continue despite treatment. This distinction helps explain why two people with similar symptoms can appropriately have different follow-up plans.

An endoscopy looks at the lining at one examination. Ambulatory reflux monitoring gathers information over time, including acid exposure and, depending on the method, other reflux events and their relationship to recorded symptoms. It answers a different question from simply looking for visible injury.

The previous evidence, current treatment and symptoms influence whether monitoring is useful and how it is performed. AGA describes different approaches for establishing unproven GERD and investigating symptoms in selected people with proven GERD. Ask what the proposed test could change. The specialist or testing service should provide the preparation and medicine instructions; do not adapt them from an article or someone else's experience.

No. AGA guidance describes functional heartburn as a diagnosis requiring an appropriate assessment, including exclusion of other relevant esophageal problems and interpretation of reflux physiology. It does not follow from a normal-looking scope or an unsuccessful medicine trial alone.

Reflux hypersensitivity is another possibility clinicians may distinguish: symptoms can be associated with reflux events despite acid exposure being within an expected range. These terms describe different clinical patterns; neither can be assigned from symptoms alone. Ask what supports a suggested explanation and what remains to be checked. A functional explanation does not mean that the discomfort is imagined.

Bring prescribed and over-the-counter products, their start dates, how you actually use them, benefits and adverse effects. Separate burning, regurgitation and other symptoms when describing the response. Persistent symptoms can have several mechanisms, and throat symptoms or chest discomfort should not automatically be assigned to reflux.

AGA recommends regular review of the reason for continuing a proton pump inhibitor, or PPI. Other conditions and bleeding risk can matter to that decision. A normal scope alone is not an instruction to stop, and concern about possible long-term adverse effects alone should not determine withdrawal. Ask the prescriber to explain the indication, expected benefit and review plan rather than increasing, switching or stopping treatment yourself.

Use the actual reports and approximate dates where necessary. Keep observations separate from the clinician's explanation. The aim is one connected account, not a list of diagnoses you need to investigate yourself.

• Main symptom: [burning, regurgitation or another sensation in my own words]; effect on meals, sleep or daily life: [ ].
• Timeline: [first onset; usual pattern; significant recent change and date; relationship to the endoscopy].
• Endoscopy date and service: [ ]; exact report available: [ ]; clinician's explanation of the findings: [ ].
• Biopsies: [taken / not taken / unsure]; purpose if known: [ ]; pathology report [available / pending / unsure].
• Previous objective reflux evidence, as explained by the clinician: [ ]; previous monitoring report available: [ ].
• For each treatment: [name; prescribed plan; actual use; start or change date; symptoms helped; symptoms remaining; adverse effects].
• Treatment around the endoscopy and any instructions received: [ ]; preparation questions for any proposed test: [ ].
• Main unanswered question: [ ]; next action, responsible service and planned review point: [ ].

Ask whether the next step is to establish the diagnosis, investigate a particular remaining symptom, review treatment or assess a new change. Clarify who will explain pending results and when to make contact if symptoms continue. Record which changes should bring that review forward. A useful plan can include uncertainty while still giving you a clear next action.